AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Therapeutic Vaccine For Earlier Stage Disease.(Brief Article)
2001 JUL 4 - (NewsRx.com & NewsRx.net) --
Dendreon Corporation (Nasdaq:DNDN) announced the expansion of its clinical trial program for Provenge(TM), its therapeutic cancer vaccine, with the initiation of a Phase III trial targeting men with earlier stage prostate cancer.
Provenge is already in Phase III trials for men with advanced hormone-refractory prostate cancer.
"It is fitting that we have chosen the commencement of National Men's Health Week to announce expansion of our Provenge clinical trial program to include patients with earlier stage prostate cancer," said Christopher S. Henney, PhD, DSc, Dendreon. "Dendreon is committed to the development of a safe and effective therapeutic product for the treatment of this prevalent disease."
Approximately 15 centers nationwide are involved in the new double-blind, placebo-controlled trial, which will enroll patients who have had their prostate surgically removed, but who have rising levels of prostate-specific antigen (PSA), indicating recurrence of disease. In this new Provenge trial, treatment will be given subsequent to three months of hormone therapy, a common therapy for recurrent prostate cancer.
...- Somatix Updates GVAX Status at H&Q Healthcare Conference; New Application in...
- Press release article from: Business Wire January 11, 1996 700+ words
...patients with prostate cancer. In addition...multi-center phase III study using GVAX...annually with prostate cancer, and that each...States due to prostate cancer has increased...discussing the planned phase III melanoma trial...
- Abbott Laboratories Provides Update on Phase III Atrasentan Clinical Trials In...
- Press release article from: PR Newswire February 10, 2003 700+ words
...atrasentan Phase III data from...end-stage prostate cancer patients...Additional Phase III studies in prostate cancer and Phase...its second Phase III pivotal trial...less advanced prostate cancer that has not...
- OncoGenex and Isis Report Encouraging Interim Phase II Data in Advanced...
- Press release article from: PR Newswire July 31, 2007 700+ words
...hormone refractory prostate cancer," said Cindy Jacobs...hormone refractory prostate cancer." OncoGenex is planning a pivotal Phase III clinical trial to evaluate...over 92 percent in prostate cancer and lymph node tissue...
- ALZA Initiates Phase III Prostate Cancer Studies for First Product...
- Press release article from: PR Newswire October 9, 1997 700+ words
...patients are being enrolled in a Phase III clinical study for the first...palliative treatment of advanced prostate cancer. The Phase III study is expected to involve...centers nationwide. If the Phase III studies are completed successfully...
- Cell Genesys initiates Phase III clinical trial of GVAX prostate cancer vaccine.
- News wire article from: Asia Africa Intelligence Wire July 15, 2004 700+ words
...multi-centre Phase III clinical trial of GVAX prostate cancer vaccine in patients...to conduct two Phase III trials of GVAX prostate cancer vaccine in metastatic...manufacturing GVAX prostate cancer vaccine for Phase III trials in its...
- IMMUNEX: PHASE III STUDY SHOWS THAT CHEMOTHERAPY DRUG NOVANTRONE CAN REDUCE...
- Press release article from: PR Newswire June 5, 1996 700+ words
...Oncology publication of a Phase III study of Novantrone...mitoxantrone) in advanced prostate cancer patients: This Phase III study demonstrated...drugs. DATA This Phase III study randomized 161 patients with prostate cancer that had spread to...
- Cell Genesys obtains special protocol assessment from FDA for Phase III trial...
- News wire article from: Asia Africa Intelligence Wire May 10, 2004 700+ words
...for its upcoming Phase III clinical trial of Gvax prostate cancer vaccine. The...the first of two Phase III trials of Gvax prostate cancer vaccine targeting...manufacture Gvax prostate cancer vaccine for Phase III trials and potential...
- Dendreon completes enrolment in Phase III PROTECT (P-11) clinical trial of...
- News wire article from: Asia Africa Intelligence Wire June 21, 2005 700+ words
...enrolment in its Phase III PROTECT...sensitive) prostate cancer. Provenge...early stage prostate cancer in a Phase III study. Dendreon...controlled Phase III trial designed...dependent prostate cancer. It is measuring...
- Data presented at AUA demonstrate Provenge significantly prolongs survival for...
- News wire article from: Chemical Business Newsbase April 28, 2009 700+ words
...announced that its pivotal Phase III IMPACT study of Provenge...T) in men with advanced prostate cancer met its primary endpoint...androgen-independent prostate cancer, and the primary endpoint...investigational therapy. Prostate cancer-specific survival also...
- Examine the Phase III Clinical Data recently Released about ACAPODENE in the...
- Press release article from: M2 Presswire April 25, 2008 700+ words
...Examine the Phase III Clinical...Treatment of Prostate Cancer(C)1994...treatment of prostate cancer to examine the phase III clinical...given for prostate cancer - Must not...participated in the phase III trial being...
Source: HighBeam Research, Therapeutic Vaccine For Earlier Stage Disease.(Brief Article)